SCHEMBL2890487

SCHEMBL2890487

CS(=O)(=O)c1ncc2cc(-c3ccccc3)c(O)nc2n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 4/20 0.43
FGFR1 P11362 2/20 0.40
SRC P12931 2/20 0.40
EGFR P00533 1/20 0.40
PDGFRB P09619 1/20 0.40
PDGFRA P16234 1/20 0.40
FGFR2 P21802 1/20 0.40
FGFR4 P22455 1/20 0.40
FGFR3 P22607 1/20 0.40
BPTF Q12830 1/20 0.39
LMNA P02545 3/20 0.38
HTT P42858 3/20 0.38
NPSR1 Q6W5P4 3/20 0.38
KMT2A Q03164 3/20 0.38
HPGD P15428 2/20 0.38
S1PR4 O95977 2/20 0.38
RAB9A P51151 2/20 0.38
TLR9 Q9NR96 2/20 0.38
MEN1 O00255 1/20 0.38
TP53 P04637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6336322 0.86 PTGS2 (0.39) PTGS2LMNAHTTNPSR1KMT2A
SCHEMBL6216960 0.84 MAPT (0.42) PTGS2FGFR1SRCLMNAHTT
SCHEMBL3712735 0.80 AKT1 (0.41) PTGS2FGFR1SRCEGFRPDGFRB
SCHEMBL13263611 0.77 ADORA1 (0.38) FGFR1SRCEGFRPDGFRBPDGFRA
SCHEMBL8130186 0.77 ADORA1 (0.55) FGFR1SRCEGFRPDGFRBPDGFRA
SCHEMBL2893433 0.76 AKT1 (0.51) KMT2AMEN1
SCHEMBL6861984 0.75 MAPT (0.43) PTGS2BPTFLMNAHTTNPSR1
SCHEMBL13233227 0.74 FGFR1 (0.37) PTGS2FGFR1SRCEGFRPDGFRB
SCHEMBL1351604 0.73 AKT1 (0.45) PTGS2FGFR1SRCEGFRPDGFRB
SCHEMBL2897546 0.73 AKT1 (0.41) FGFR1SRCEGFRPDGFRBPDGFRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7750151-B2 Inhibitors of Akt activity MERCK SHARP & DOHME CORP. (US) 2010-07-06 US disclosed
US-7544677-B2 Inhibitors of Akt activity MERCK & CO., INC. (US) 2009-06-09 US disclosed
US-20080280899-A1 Inhibitors of Akt Activity MERCK SHARP & DOHME CORP. 2008-11-13 US disclosed
US-20070254901-A1 Inhibitors of Akt Activity MERCK SHARP & DOHME CORP. 2007-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080280899-A1 Inhibitors of Akt Activity AKT1, AKT2, AKT3 PTGS2 4138/4885FGFR1 1412/4885SRC 55/4885
US-20070254901-A1 Inhibitors of Akt Activity AKT1, AKT2, PIK3CD PTGS2 2741/4885FGFR1 2811/4885SRC 113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.